GSA Capital Partners’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151K | Buy |
19,591
+206
| +1% | +$1.59K | 0.01% | 1570 |
|
|
2025
Q1 | $115K | Buy |
+19,385
| New | +$115K | 0.01% | 1480 |
|
|
2024
Q1 | – | Sell |
-31,375
| Closed | -$402K | – | 1595 |
|
|
2023
Q4 | $402K | Buy |
+31,375
| New | +$402K | 0.03% | 939 |
|
|
2023
Q2 | – | Sell |
-2,821
| Closed | -$205K | – | 1507 |
|
|
2023
Q1 | $205K | Buy |
2,821
+2,117
| +301% | +$154K | 0.02% | 1244 |
|
|
2022
Q4 | $58K | Sell |
704
-1,504
| -68% | -$124K | 0.01% | 1349 |
|
|
2022
Q3 | $209K | Buy |
+2,208
| New | +$209K | 0.03% | 1194 |
|
|
2022
Q2 | – | Sell |
-579
| Closed | -$134K | – | 1391 |
|
|
2022
Q1 | $134K | Sell |
579
-396
| -41% | -$91.6K | 0.02% | 1250 |
|
|
2021
Q4 | $384K | Buy |
+975
| New | +$384K | 0.05% | 767 |
|
|
2021
Q2 | – | Sell |
-520
| Closed | -$187K | – | 1311 |
|
|
2021
Q1 | $187K | Buy |
+520
| New | +$187K | 0.03% | 926 |
|